Transforming growth factor beta 1 (TGF-beta 1) produced in tumour tissue after chemotherapy acts as a lymphokine-activated killer attractant.

por Kuramitsu, Y., Nishibe, M., Kobayashi, M., Togashi, Y., Yuan, L., Takizawa, M., Okada, F., Hosokawa, M.
Publicado 1996

Enhancement of in vitro prostaglandin E2 production by mouse fibrosarcoma cells after co-culture with various anti-tumour effector cells.

por Okada, F., Hosokawa, M., Hasegawa, J., Kuramitsu, Y., Nakai, K., Yuan, L., Lao, H., Kobayashi, H., Takeichi, N.
Publicado 1994

Malignant progression of a mouse fibrosarcoma by host cells reactive to a foreign body (gelatin sponge).

por Okada, F., Hosokawa, M., Hamada, J. I., Hasegawa, J., Kato, M., Mizutani, M., Ren, J., Takeichi, N., Kobayashi, H.
Publicado 1992

Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase

por Okada, F, Shionoya, H, Kobayashi, M, Kobayashi, T, Tazawa, H, Onuma, K, Iuchi, Y, Matsubara, N, Ijichi, T, Dugas, B, Hosokawa, M
Publicado 2006

Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma

por Kaya, M, Wada, T, Kawaguchi, S, Nagoya, S, Yamashita, T, Abe, Y, Hiraga, H, Isu, K, Shindoh, M, Higashino, F, Okada, F, Tada, M, Yamawaki, S, Ishii, S
Publicado 2002

Inflammatory cell-mediated tumour progression and minisatellite mutation correlate with the decrease of antioxidative enzymes in murine fibrosarcoma cells

por Okada, F, Nakai, K, Kobayashi, T, Shibata, T, Tagami, S, Kawakami, Y, Kitazawa, T, Kominami, R, Yoshimura, S, Suzuki, K, Taniguchi, N, Inanami, O, Kuwabara, M, Kishida, H, Nakae, D, Konishi, Y, Moriuchi, T, Hosokawa, M
Publicado 1999